MS PHARMA’s Post

Twaireat Medical’s decision to list on Saudi Arabia’s Nomu market highlights the continued growth and diversification of the Kingdom’s healthcare sector. By entering the parallel market, the company gains access to greater funding opportunities, supporting its expansion and ability to deliver innovative medical solutions in line with Vision 2030’s objectives. This move not only reflects investor confidence in the healthcare industry but also encourages other private sector firms to explore public offerings. As Twaireat Medical embarks on this journey, it strengthens the evolving relationship between healthcare development and Saudi Arabia’s economic transformation.

Our Tamer Monlycke Care project in revolutionizing medical device manufacturing in Saudi Arabia.

I believe there is a misconception of foreign investors who are interested in investing in Saudi medical laboratories market. Given the reports reported by MOH the number of tests are increasing in consistant basis and varies between 5-10 %. Regardless of the external factors including the pandemic, the growing population is a key driving factor, the anticipated rate of aging which is expected to start after 2040 as most of the Saudi population is under the age of 30. Furthermore, the major challenge in Saudi medical laboratories market today is the infrastructure, which includes : 1. Skilled professionals 2. Logistic services Which opens new areas of investments to support the market to grow rapidly and deliver the best services to the clients. #healthcare #SaudiArabia

Join us on May 20 at 7 p.m. KSA time for an insightful "Critical Appraisal of Clinical Trial Study Designs: Evaluating Strengths and Limitations" session by Dr. Samaa Al Tabbah. This event is perfect for anyone keen on understanding the nuances of clinical trial study designs, their strengths, and limitations. Whether you're a healthcare professional, researcher, or interested in the field, this session promises valuable insights. Key highlights: - In-depth analysis of various clinical trial study designs - Evaluation of strengths and limitations - Expert-led discussions and Q&A session Mark your calendars and register now to secure your spot! Register here:  https://lnkd.in/djBHD9YG Dr. Kanika Vats Ph.D. (c), FISQua, CS, GCP, RPh.Reem Ahmed Muna Barakat Anhar BaballaZhinya Kawa Abrar AbuHamdiaFaten Hamed Abdullah Alanazi, Ph.D. Mina EmadSundus Shukar Noor Breik Hossameldin Saber Hind Haddadi #ClinicalResearch #ClinicalTrials #HealthcareEducation #ContinuousLearning #KnowledgeSharing #ProfessionalDevelopment

Join us on May 20 at 7 p.m. KSA time for an insightful "Critical Appraisal of Clinical Trial Study Designs: Evaluating Strengths and Limitations" session by Dr. Samaa Al Tabbah. This event is perfect for anyone keen on understanding the nuances of clinical trial study designs, their strengths, and limitations. Whether you're a healthcare professional, researcher, or interested in the field, this session promises valuable insights. Key highlights: - In-depth analysis of various clinical trial study designs - Evaluation of strengths and limitations - Expert-led discussions and Q&A session Mark your calendars and register now to secure your spot! Register here:  https://lnkd.in/djBHD9YG Dr. Kanika Vats Ph.D. (c), FISQua, CS, GCP, RPh.Reem Ahmed Muna Barakat Anhar BaballaZhinya Kawa Abrar AbuHamdiaFaten Hamed Abdullah Alanazi, Ph.D. Mina EmadSundus Shukar Noor Breik Hossameldin Saber Hind Haddadi #ClinicalResearch #ClinicalTrials #HealthcareEducation #ContinuousLearning #KnowledgeSharing #ProfessionalDevelopment

Developing a groundbreaking drug is only half the battle. 🇸🇦 In Saudi Arabia's evolving healthcare landscape, #PatientExperience tracking will be key to successful #ClinicalTrials and post-market adoption. Here's why: 🏔 Uncover real-world challenges: Go beyond clinical data to understand how #TrialDesign, medication access, and #communication impact patient experience in Saudi Arabia. 🏣 Boost #TrialRetention: Identify and address pain points early-on, leading to higher patient satisfaction and increased trial completion rates. 📈 Optimize post-launch success: Gain valuable insights to shape #PatientAdherence programs and communication strategies for a smooth market entry. Interested in what data will be collected in Saudi Arabia? Find out more below! #PatientExperience #MarketAccess #ClinicalTrial

In a recent interview with Dr. Tamara Sunbul, MD, MBA, FHIMSS, CPHIMS, PMP, a leader in digital health clinical trials, she shared valuable insights into the evolving landscape of digital health and clinical research in Saudi Arabia. Dr. Sunbul emphasized the importance of integrating clinical trials within standard medical procedures to enhance patient enrollment and retention. She highlighted that conducting traditional exams alongside digital trials not only respects cultural preferences but also ensures patients feel secure and supported throughout the process. Addressing the challenges of attracting Big Pharma funding, Dr. Sunbul pointed out that Saudi Arabia offers abundant funding opportunities across multiple sectors, fostering a collaborative ecosystem that appeals to developers and supports innovation. She also noted that while international collaborations are pursued, all trials must be re-registered locally to meet Saudi regulatory standards and address population-specific data biases, ensuring the relevance and quality of research outcomes. Dr. Sunbul's insights shed light on the strategic approaches being implemented to navigate the complexities of digital health and clinical trials in Saudi Arabia, paving the way for advancements in patient care and medical research. #clinicaltrials #saudi #saudiarabia #digitalhealth

In an era where healthcare is rapidly evolving, the introduction of innovative medical devices in Saudi Arabia significantly enhances patient safety. As the nation advances in its healthcare infrastructure, the integration of cutting-edge technology not only improves treatment outcomes but also fosters a more robust healthcare environment. Innovative medical devices enable precise diagnostics, minimize human error, and enhance procedural efficiency. These advancements are particularly pivotal in critical care scenarios, where timely and accurate interventions can be the difference between life and death. Furthermore, the commitment to patient safety is reinforced through rigorous compliance with international standards, ensuring that Saudi patients receive treatments that are not only effective but also safe. At POINT Medical, we are dedicated to bringing top-quality medical devices to the Saudi market, aligned with our mission to prioritize patient safety and foster strong global partnerships. By collaborating with leading technology providers, we are positioned to contribute to the ongoing transformation of healthcare in the region. As we continue to champion innovation in medical devices, we encourage healthcare professionals to embrace these advancements, which ultimately serve to protect our most valuable asset: the patient. #PatientSafety #MedicalDevices #HealthcareInnovation #SaudiArabia #POINTMedical #MedicalTechnology #HealthcareExcellence

Al-Baha Region to Build $2bn Medical Facility. Saudi Arabia’s Al-Baha region a $2 billion medical city development takes shape, reinforcing the Kingdom’s commitment to healthcare excellence. 🔹 A Memorandum of Understanding was signed between Virtus Health Partners (VHP) and the Saudi ministries of investment and health to develop the Jebel Al-Noor Medical City. 🔹 This state-of-the-art facility, part of Vision 2030, aims to be a medical hub, delivering advanced treatments and cutting-edge education in one integrated ecosystem. 🔹 Phased Development: Over the next 10 years, the project will begin with a medical school teaching hospital, bridging the gap between education and real-world patient care. 🔹 In partnership with Mayo Clinic as a strategic advisor, this project will set new standards in healthcare education and infrastructure across the region. Why This Matters: As an entrepreneur with a focus on strategic collaborations, FDI promotion, and real estate investment advisory in KSA, opportunities like these are instrumental for creating lasting partnerships and expanding investment channels in the healthcare sector. This massive project aligns perfectly with Saudi Arabia’s Health Sector Transformation Program, aiming to reshape the nation’s healthcare infrastructure and foster global collaborations. If you're seeking ways to explore mergers, acquisitions, or partnership opportunities in the medical sector or beyond, let's connect! #SaudiVision2030 #HealthcareInnovation #FDIPromotion #StrategicPartnerships #BusinessStrategy #InvestmentAdvisory #MedicalInfrastructure #MergersAndAcquisitions #AlBahaDevelopment #MayoClinic #Shan

MEDICAL PLAN COST IN EGYPT Medical Plan Cost Increase In 2024 Egypt is expected to see a 29% rise in medical plan costs significantly surpassing the global average increase of 10.1%.